Viewing SEC Facts Units
Company Name:
Xilio Therapeutics, Inc.
CIK:
1840233
Start Filing Date:
End Filing Date:
2023-08-04
ACCN:
0001558370-23-018576
Value:
$ 27,539,620
Value Error:
$ None
Created By:
Date Filed:
2023-11-09
FY:
2023
Fiscal Period:
Q2
Frame:
CY2023Q2I
Type:
dei
Form:
10-Q/A
Units:
shares